Evidence map›Paper›PMID 28500878›Full record

ArticleNeurobiology of aging2017

Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach.

Sarah N Fontaine, Alexandria Ingram, Ryan A Cloyd, Shelby E Meier, Emily Miller, Danielle Lyons, Grant K Nation, Elizabeth Mechas, Blaine Weiss, Chiara Lanzillotta and 5 more

Abstract read
In one paragraph

Article in Neurobiology of aging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Manganese-Enhanced Magnetic Resonance Imaging of the Heart.Journal of magnetic resonance imaging : JMRI · 2023
    Review
  3. Frontiers in neuroscience · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Broad Kinase Inhibition Mitigates Early Neuronal Dysfunction in Tauopathy.International journal of molecular sciences · 2021
    Article
  10. Magnetic Resonance Imaging in Tauopathy Animal Models.Frontiers in aging neuroscience · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Frontiers in neurology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sarah N FontaineSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA; Epilepsy Center, University of Kentucky, Lexington, KY, USA.
Alexandria IngramSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Ryan A CloydSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Shelby E MeierSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA; Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY, USA.
Emily MillerSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Danielle LyonsSpinal Cord Injury and Brain Injury Research Center, University of Kentucky, Lexington, KY, USA.
Grant K NationSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Elizabeth MechasSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Blaine WeissSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Chiara LanzillottaDepartment of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
Fabio Di DomenicoDepartment of Biochemical Sciences, Sapienza University of Rome, Rome, Italy.
Frederick SchmittSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
David K PowellDepartment of Biomedical Engineering, University of Kentucky, Lexington, KY, USA.
Moriel VandsburgerDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY, USA; Department of Biomedical Engineering, University of Kentucky, Lexington, KY, USA.
Jose F AbisambraSanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA; Epilepsy Center, University of Kentucky, Lexington, KY, USA; Department of Physiology, College of Medicine, University of Kentucky, Lexington, KY, USA; Spinal Cord Injury and Brain Injury Research Center, University of Kentucky, Lexington, KY, USA. Electronic address: joe.abisambra@uky.edu.

Funding

University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI SCHMITT, FREDERICK · 2006 to 2020
$23.3M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
Protein CoreP30GM110787 · NIGMS · UNIVERSITY OF KENTUCKY · PI MENDENHALL, MICHAEL D. · 2014 to 2018
$5.7M
PERK as a Central Mediator of Neurotoxicity in TauopathiesR01NS091329 · NINDS · UNIVERSITY OF KENTUCKY · PI ABISAMBRA, JOSE FRANCISCO · 2015 to 2019
$1.6M
NCATS NIH HHS UL1 TR000117NIA NIH HHS P30 AG028383NIGMS NIH HHS P30 GM110787NIMHD NIH HHS L32 MD009205NINDS NIH HHS R01 NS091329
6 · The paper itself

Abstract

Tauopathies, the most common of which is Alzheimer's disease (AD), constitute the most crippling neurodegenerative threat to our aging population. Tauopathic patients have significant cognitive decline accompanied by irreversible and severe brain atrophy, and it is thought that neuronal dysfunction begins years before diagnosis. Our current understanding of tauopathies has yielded promising therapeutic interventions but have all failed in clinical trials. This is partly due to the inability to identify and intervene in an effective therapeutic window early in the disease process. A major challenge that contributes to the definition of an early therapeutic window is limited technologies. To address these challenges, we modified and adapted a manganese-enhanced magnetic resonance imaging (MEMRI) approach to provide sensitive and quantitative power to detect changes in broad neuronal function in aging mice. Considering that tau tangle burden correlates well with cognitive impairment in Alzheimer's patients, we performed our MEMRI approach in a time course of aging mice and an accelerated mouse model of tauopathy. We measured significant changes in broad neuronal function as a consequence of age, and in transgenic mice, before the deposition of bona fide tangles. This MEMRI approach represents the first diagnostic measure of neuronal dysfunction in mice. Successful translation of this technology in the clinic could serve as a sensitive diagnostic tool for the definition of effective therapeutic windows.

Indexed as

AgingAlzheimer DiseaseAnimalsDisease Models, AnimalEarly DiagnosisHumansMagnetic Resonance ImagingManganeseMice, TransgenicNeurodegenerative DiseasesNeuroimagingNeuronsSensitivity and SpecificityTauopathiesManganeseAlzheimerManganeseMEMRIrTg4510TanglesTau

Identifiers

PMID28500878
PMCPMC5524451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.